Case Report: Shewanella algae, a rare cause of osteosynthesis-associated infection.

Q2 Pharmacology, Toxicology and Pharmaceutics
F1000Research Pub Date : 2024-09-02 eCollection Date: 2023-01-01 DOI:10.12688/f1000research.142096.2
Sofiane Masmoudi, Mohamed Ali Khlif, Hajer Battikh, Meriam Zribi, Maher Barsaoui, Khaled Zitouna
{"title":"Case Report: <i>Shewanella algae</i>, a rare cause of osteosynthesis-associated infection.","authors":"Sofiane Masmoudi, Mohamed Ali Khlif, Hajer Battikh, Meriam Zribi, Maher Barsaoui, Khaled Zitouna","doi":"10.12688/f1000research.142096.2","DOIUrl":null,"url":null,"abstract":"<p><p><i>Shewanella</i> is an emerging human pathogen. It mostly causes skin and soft tissue infections. Osteosynthesis-associated infection involving <i>Shewanella</i> are rare and in most cases are secondary to direct contamination following open fractures in aquatic environments. Here, we present a rare case of hematogenous osteosynthesis-associated infection involving <i>Shewanella algae</i> affecting an 18-year-old patient who was operated on for 12 <sup>th</sup> thoracic vertebrae and 4th lumbar vertebrae fractures occurring in an aquatic environment. We performed surgical debridement with subsequent double course parenteral antibiotherapy that was then adapted to bacteria sensitivities for three weeks. After a follow-up of six months, the patient had no signs of recurrent infection. The presence of infected dermabrasions and the concordance between germs isolated in operative samples and in blood cultures presumes that the contamination was hematogenous.</p>","PeriodicalId":12260,"journal":{"name":"F1000Research","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11375409/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"F1000Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12688/f1000research.142096.2","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

Abstract

Shewanella is an emerging human pathogen. It mostly causes skin and soft tissue infections. Osteosynthesis-associated infection involving Shewanella are rare and in most cases are secondary to direct contamination following open fractures in aquatic environments. Here, we present a rare case of hematogenous osteosynthesis-associated infection involving Shewanella algae affecting an 18-year-old patient who was operated on for 12 th thoracic vertebrae and 4th lumbar vertebrae fractures occurring in an aquatic environment. We performed surgical debridement with subsequent double course parenteral antibiotherapy that was then adapted to bacteria sensitivities for three weeks. After a follow-up of six months, the patient had no signs of recurrent infection. The presence of infected dermabrasions and the concordance between germs isolated in operative samples and in blood cultures presumes that the contamination was hematogenous.

病例报告:鞘氨醇藻类,骨合成相关感染的罕见病因。
雪旺菌是一种新出现的人类病原体。它主要引起皮肤和软组织感染。涉及雪旺菌的骨合成相关感染非常罕见,大多数情况下是继发于水生环境中开放性骨折后的直接污染。这里,我们介绍一例罕见的血源性骨合成相关感染病例,感染者是一名18岁的患者,因在水生环境中发生第12胸椎和第4腰椎骨折而接受手术。我们为他进行了手术清创,随后根据细菌的敏感性进行了为期三周的双疗程肠外抗生素治疗。经过六个月的随访,患者没有出现复发感染的迹象。感染皮损的存在以及手术样本和血液培养物中分离出的病菌之间的一致性推测,污染是血源性的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
F1000Research
F1000Research Pharmacology, Toxicology and Pharmaceutics-Pharmacology, Toxicology and Pharmaceutics (all)
CiteScore
5.00
自引率
0.00%
发文量
1646
审稿时长
1 weeks
期刊介绍: F1000Research publishes articles and other research outputs reporting basic scientific, scholarly, translational and clinical research across the physical and life sciences, engineering, medicine, social sciences and humanities. F1000Research is a scholarly publication platform set up for the scientific, scholarly and medical research community; each article has at least one author who is a qualified researcher, scholar or clinician actively working in their speciality and who has made a key contribution to the article. Articles must be original (not duplications). All research is suitable irrespective of the perceived level of interest or novelty; we welcome confirmatory and negative results, as well as null studies. F1000Research publishes different type of research, including clinical trials, systematic reviews, software tools, method articles, and many others. Reviews and Opinion articles providing a balanced and comprehensive overview of the latest discoveries in a particular field, or presenting a personal perspective on recent developments, are also welcome. See the full list of article types we accept for more information.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信